Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 1
1966 2
1967 4
1968 5
1969 12
1970 14
1971 13
1972 23
1973 26
1974 23
1975 24
1976 19
1977 39
1978 24
1979 30
1980 32
1981 37
1982 48
1983 29
1984 18
1985 38
1986 22
1987 18
1988 31
1989 25
1990 19
1991 27
1992 26
1993 40
1994 45
1995 42
1996 35
1997 33
1998 44
1999 38
2000 43
2001 31
2002 27
2003 32
2004 44
2005 46
2006 34
2007 31
2008 35
2009 31
2010 33
2011 39
2012 32
2013 34
2014 54
2015 54
2016 53
2017 41
2018 58
2019 50
2020 43
2021 46
2022 45
2023 7
Text availability
Article attribute
Article type
Publication date

Search Results

1,754 results
Results by year
Filters applied: . Clear all
Page 1
Variability and quantification of serum medroxyprogesterone acetate levels.
Bick AJ, Skosana SB, Avenant C, Hapgood JP. Bick AJ, et al. Steroids. 2022 Nov;187:109100. doi: 10.1016/j.steroids.2022.109100. Epub 2022 Aug 12. Steroids. 2022. PMID: 35964796 Review.
Many such studies are focussed on the three-monthly progestin-only intramuscular (IM) injectable contraceptive depot medroxyprogesterone acetate (DMPA-IM). ...Standardization of quantification methods and sampling time post-injection is required to imp …
Many such studies are focussed on the three-monthly progestin-only intramuscular (IM) injectable contraceptive depot medroxyproges
Retrospective review of the relationship between weight change and demographic factors following initial depot medroxyprogesterone acetate injection in adolescents.
Gerlach LS, Saldaña SN, Wang Y, Nick TG, Spigarelli MG. Gerlach LS, et al. Clin Ther. 2011 Feb;33(2):182-7. doi: 10.1016/j.clinthera.2011.02.008. Epub 2011 Mar 12. Clin Ther. 2011. PMID: 21397330 Review.
BACKGROUND: Depot medroxyprogesterone acetate (DMPA) is an effective (<1% annual failure rate) contraceptive administered by intramuscular injection every 3 months. ...
BACKGROUND: Depot medroxyprogesterone acetate (DMPA) is an effective (<1% annual failure rate) contraceptive administered b …
Depo-medroxyprogesterone acetate, weight gain and amenorrhea among obese adolescent and adult women.
Sims J, Lutz E, Wallace K, Kassahun-Yimer W, Ngwudike C, Shwayder J. Sims J, et al. Eur J Contracept Reprod Health Care. 2020 Feb;25(1):54-59. doi: 10.1080/13625187.2019.1709963. Epub 2020 Jan 13. Eur J Contracept Reprod Health Care. 2020. PMID: 31928370 Free PMC article.
Objective: The aim of the study was to evaluate the correlation between obesity and the use of depot medroxyprogesterone (DMPA) with regard to weight gain and changes in bleeding pattern.Methods: A retrospective chart review was conducted of women receiving 150 mg DMPA via …
Objective: The aim of the study was to evaluate the correlation between obesity and the use of depot medroxyprogesterone (DMPA) with …
Self-administered subcutaneous medroxyprogesterone acetate for improving contraceptive outcomes: a systematic review and meta-analysis.
Nabhan A, Elshafeey F, Mehrain LM, Kabra R, Elshabrawy A. Nabhan A, et al. BMC Womens Health. 2021 Oct 9;21(1):359. doi: 10.1186/s12905-021-01495-y. BMC Womens Health. 2021. PMID: 34627229 Free PMC article.
BACKGROUND: Subcutaneous depot medroxyprogesterone acetate is an easy-to-use injectable contraceptive. A trained person can administer it, including women through self-injection. The objective of this systematic review and meta-analysis was to assess t …
BACKGROUND: Subcutaneous depot medroxyprogesterone acetate is an easy-to-use injectable contraceptive. A trained person …
Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics.
Thurman A, Kimble T, Hall P, Schwartz JL, Archer DF. Thurman A, et al. Contraception. 2013 Jun;87(6):738-43. doi: 10.1016/j.contraception.2012.11.010. Epub 2012 Dec 22. Contraception. 2013. PMID: 23265980 Clinical Trial.
BACKGROUND: Cyclofem is a combined injectable contraceptive, containing medroxyprogesterone acetate (MPA) and estradiol cypionate. ...Mean estradiol levels peaked at 254 pg/mL by 3.3 days. Ovulation was suppressed for at least 77 days post third injection
BACKGROUND: Cyclofem is a combined injectable contraceptive, containing medroxyprogesterone acetate (MPA) and estradiol …
The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
Rosenfield A, Maine D, Rochat R, Shelton J, Hatcher RA. Rosenfield A, et al. JAMA. 1983 Jun 3;249(21):2922-8. JAMA. 1983. PMID: 6221125
In 1978, the Food and Drug Administration denied approval of the three-month injectable contraceptive depot medroxyprogesterone acetate for use in the United States. ...Reviewing the scientific literature on the risks and benefits of depot medroxyprogester
In 1978, the Food and Drug Administration denied approval of the three-month injectable contraceptive depot medroxyprogesterone
A prospective cohort study of the feasibility and acceptability of depot medroxyprogesterone acetate administered subcutaneously through self-injection.
Cover J, Namagembe A, Tumusiime J, Lim J, Drake JK, Mbonye AK. Cover J, et al. Contraception. 2017 Mar;95(3):306-311. doi: 10.1016/j.contraception.2016.10.007. Epub 2016 Oct 24. Contraception. 2017. PMID: 27789309 Free PMC article.
There are no published studies on the feasibility of contraceptive self-injection in sub-Saharan Africa to date. The purpose of this study was to assess feasibility of subcutaneous depot medroxyprogesterone acetate self-injection in Uganda, with specif …
There are no published studies on the feasibility of contraceptive self-injection in sub-Saharan Africa to date. The purpose of this …
The relationship between progestin hormonal contraception and depression: a systematic review.
Worly BL, Gur TL, Schaffir J. Worly BL, et al. Contraception. 2018 Jun;97(6):478-489. doi: 10.1016/j.contraception.2018.01.010. Epub 2018 Feb 26. Contraception. 2018. PMID: 29496297
No correlation with depression was found in five low-quality, high-risk-of-bias progestin subdermal implant studies and four out of five varying-quality and medium-risk-of-bias levonorgestrel intrauterine device studies. Three medroxyprogesterone acetate intramuscul …
No correlation with depression was found in five low-quality, high-risk-of-bias progestin subdermal implant studies and four out of five var …
Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study.
Cover J, Ba M, Lim J, Drake JK, Daff BM. Cover J, et al. Contraception. 2017 Sep;96(3):203-210. doi: 10.1016/j.contraception.2017.06.010. Epub 2017 Jun 30. Contraception. 2017. PMID: 28673645 Free PMC article.
This study was performed to assess feasibility of subcutaneous DMPA self-injection in Senegal; objectives were to (1) measure the proportion of participants who self-injected competently 3 months after training, (2) measure the proportion who self-injected on …
This study was performed to assess feasibility of subcutaneous DMPA self-injection in Senegal; objectives were to (1) measure the pro …
1,754 results